Literature DB >> 23926211

Pellagra encephalopathy in the context of alcoholism: review and case report.

Marta López1, José M Olivares, German E Berrios.   

Abstract

AIMS: The aim of the study was to review and describe the Alcoholic Pellagra Encephalopathy, a severe neuropsychiatric condition caused by a combination of niacin (vitamin B3) deficiency and alcohol abuse.
METHODS: PsychInfo, Medline and Embase databases were searched for peer-reviewed studies addressing this illness.
RESULTS: A historical and conceptual review of the psychopathological aspects of this condition is offered, followed by the report of a patient with a history of chronic alcohol consumption showing signs of pellagra, delusions and visual hallucinations, which was treated successfully with niacin.
CONCLUSION: Pellagra encephalopathy should still be considered in the differential diagnosis of acute psychotic disorders seen in the context of chronic alcoholism.

Entities:  

Mesh:

Year:  2013        PMID: 23926211     DOI: 10.1093/alcalc/agt070

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  4 in total

1.  A case of alcoholic pellagra encephalopathy presenting with spinal myoclonus.

Authors:  Kwiyoung Park; Tomoko Oeda; Hideyuki Sawada
Journal:  Neurol Clin Pract       Date:  2015-12

2.  Wernicke encephalopathy and pellagra in an alcoholic and malnourished patient.

Authors:  Norihiko Terada; Kensuke Kinoshita; Shijima Taguchi; Yasuharu Tokuda
Journal:  BMJ Case Rep       Date:  2015-10-21

3.  Diagnosis of Lingual Atrophic Conditions: Associations with Local and Systemic Factors. A Descriptive Review.

Authors:  M Erriu; F M G Pili; S Cadoni; V Garau
Journal:  Open Dent J       Date:  2016-11-16

4.  Erythrodermic Psoriasis in a Patient with Plaque Psoriasis Who Presented with Symptoms of Niacin Deficiency: A Special Case Report.

Authors:  Hao Wu; Yanna Shen; Li Zhang; Mouzhe Yang; Yougang Ren; Feng Mao; Zhongxiao Wu
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.